ThursdayDec 29, 2022 12:19 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures 28th Patent in International Portfolio

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its continued accumulation of international patent recognition with the receipt of its first granted patent in Canada, which is its 28th granted patent worldwide. According to the update, Canadian Patent #3,093,414 is the first granted patent from Lexaria’s sixth patent family and is entitled “Transdermal and/or Dermal Delivery of Lipophilic Active Agents.” The patent covers improved compositions and methods for dermal and transdermal delivery of cannabinoids, including cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”). Similar patent applications for skin-based delivery of DehydraTECH(TM) formulations are pending in many other…

Continue Reading

ThursdayDec 29, 2022 10:17 am

TinyGemsBreaks – Tingo Inc. (TMNA) Partners with Dozy Mmobousi to Open Leadership Centre

Tingo (OTC: TMNA), a leading agrifintech business in Africa, and Dozy Mmobuosi, renowned technology entrepreneur and philanthropist, have together unveiled the Dozy Mmobuosi Leadership Centre (DMLC), located in Oxford, United Kingdom. The centre is designed to offer a monthlong, in-person transformational leadership program for entrepreneurs and those involved in both private and public service. The centre is scheduled to welcome its first cohort of approximately 35 African leaders in February 2023. The centre can also be used as a meeting point for world leaders and researchers for high-level events. According to the announcement, Rt. Hon. Mark Simmonds will serve as the chair…

Continue Reading

TuesdayDec 27, 2022 1:40 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes on Acquisition of Multinational Medical Cannabis Operator

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has completed a “plan of arrangement,” or acquisition, of Franchise Global Health Inc. (TSX.V: FGH), a multinational operator in the medical cannabis and pharmaceutical industry with principal operations in Germany. Shareholders of Global Health Inc. approved the plan, which was effective as of Dec. 23, 2022. FLGC anticipates that the acquisition will provide a direct connection between Flora Growth’s Colombian-grown cannabis and German-based pharmaceutical and medical cannabis distribution. The company also noted that the acquisition will establish a foothold in Germany for medical cannabis…

Continue Reading

TuesdayDec 27, 2022 12:24 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast, Secures New Contracts Spanning Multiple States

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release highlights Knightscope’s recent securement of its largest single contract to date alongside two new contracts from cities in New York and Georgia. “Knightscope continues to deliver on its promise to rapidly grow the company and help make the United States of America the safest country in the world,” William Santana Li, chairman and CEO of Knightscope,…

Continue Reading

TuesdayDec 27, 2022 11:54 am

TinyGemsBreaks – Vision Energy Corp. (VENG) Increases Core Team to Realize Project Development Objectives

Vision Energy (OTCQB: VENG) today provided an update on the expansion of its project management and development team. According to the announcement, Vision Energy, through its wholly owned Dutch subsidiary Evolution Terminals BV (“ETBV”), continues work to realize its project development objectives and has increased its core team of experienced commercial and engineering professionals. Since its December 2020 incorporation, ETBV has been executing its mission to design and develop a pioneering Green Energy Hub for renewable products, hydrogen carriers and low-carbon fuels. In March 2021, ETBV engaged professionals from Rotterdam-based Riverlake Solutions, a specialist project development and engineering consultancy to…

Continue Reading

ThursdayDec 22, 2022 11:31 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces I-GO European Arrival

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that its I-GO(TM) Commercial Urban Delivery EV has arrived in Europe; specifically, sample vehicles are on their way to Ireland-based Newgate Motor Group, with an expected delivery for early next month. Initially, delivery was scheduled for December, but COVID-related shutdown issues caused the delay. According to the announcement, Mullen’s I-GO is an urban commercial delivery vehicle designed to meet the growing demand for quick deliveries in dense cities throughout Europe that have space constraints; the I-GO is EU standard homologated, certified, and ready for sale in initial markets…

Continue Reading

WednesdayDec 21, 2022 3:59 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys ASR and Emergency Communication Services for Five New Contracts

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced continued market expansion through securing five new contracts for its Autonomous Security Robot (“ASR”) and Blue Light Emergency Communication services across multiple U.S. states. The contracts and deployment locations include a property management group in Chicago, a police department in North Carolina, another tribal casino client in Oklahoma, an airport in New Jersey, as well as a construction company in Texas. The announcement reads, “Knightscope’s expanded product line is helping its clients protect the places people live, work, study and visit in many new ways. In addition to…

Continue Reading

WednesdayDec 21, 2022 2:42 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD (TM) Achieves Superior CBD Blood Absorption Levels in Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has demonstrated superior cannabidiol (“CBD”) blood absorption levels from its patented DehydraTECH-CBD(TM) relative to those of published, pharmaceutical-grade CBD industry comparators. The results were obtained from the company’s recently completed, multi-week human clinical hypertension study – HYPER-H21-4. “DehydraTECH-CBD has repeatedly shown that it can be administered at much lower dose levels than other CBD formulations to achieve effective levels within the blood stream, as supported by this pharmaceutical-industry peer comparison,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “This is extremely important to patients…

Continue Reading

WednesdayDec 21, 2022 1:57 pm

TinyGemsBreaks – Vision Energy Corp. (VENG) Issues Development Update on Green Energy Hub

Vision Energy (OTCQB: VENG) today provided a project development update on the company’s Green Energy Hub in the North Sea Port of Vlissingen, the Netherlands. According to the update, Vision Energy, through its wholly owned subsidiary Evolution Terminals BV, is concluding remaining requisite studies to support filing permit applications under the Dutch “WABO” process, with targeted first submission by Dec. 31, 2022. The submission includes filing of an environmental permit followed by construction permit application for phase 1 400,000 cubic meters (“CBM”) capacity. The latter will be a phased submission, with each phase designed in accordance with commercial storage requirements…

Continue Reading

TuesdayDec 20, 2022 3:25 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing has begun in its human clinical nicotine study NIC-H22-1. Current cigarette smokers are participating in the 36-person human pharmacokinetic randomized, double blinded, cross-over study, wherein each person will visit the laboratory to be dosed three times over the coming weeks. Only one oral nicotine pouch (DehydraTECH-nicotine, On! brand manufactured by Altria, or Zyn brand manufactured by Swedish Match) will be administered and evaluated during each visit. The primary objectives are to determine the quantity of nicotine in blood at various time points and collection…

Continue Reading

Contact us: (310) 299-1717